Trials / Completed
CompletedNCT01912326
Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 249 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of dynamic Atrial Overdrive Stimulation using the AF Suppression Algorithm to prevent atrial tachyarrhythmias in patients with more than 2% Auto Mode Switch Episodes with optimized pacemaker programming. Hypothesis: Dynamic atrial Overdrive (AF Suppression) reduces AT/AF Burden by 30% as compared to programming DDDR-(60) without AF Suppression when all other parameters are optimized.
Detailed description
Atrial Fibrillation is the most common Heart Rhythm Disorder requiring therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pacemaker Implantation | Implantation of a dual chamber pacemaker |
Timeline
- Start date
- 2002-07-01
- Primary completion
- 2008-01-01
- Completion
- 2008-04-01
- First posted
- 2013-07-31
- Last updated
- 2024-10-08
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01912326. Inclusion in this directory is not an endorsement.